Skip to content

Author

M. Abdel-Kader

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Adamantane-based scaffolds: Synthesis, DFT, docking and potential as anticancer agents via CDC25A inhibition.

The findings suggest adamantane as a feasible backbone to develop anticancer agents which may act in-part via CDC25A interaction, suggest adamantane as a feasible backbone to develop anticancer agents which may act in-part via CDC25A.

M. Alamri, Yassine Riadi, M. Alamri et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.